Diskussionsleiter: P. Kahlert (Essen)
| (P474) | Effect of PVL after TAVI is different according to baseline LVEF and NT-pro BNP level | |
| H. Kaneko, F. Hölschermann, G. Tambor, M. Neuß, C. Butter (Bernau b. Berlin) | ||
| (P475) | Systemic inflammatory response after conventional versus transcatheter aortic valve replacement | |
| C. Castrup, M. A. Weigand, C. Lichtenstern, F. Uhle, P. Grieshaber, A. Necaeva, A. Böning (Gießen, Heidelberg) | ||
| (P476) | Increased levels of Gremlin-1 and MIF but not TGF-ß1 are associated with severe valvular aortic stenosis in symptomatic patients undergoing aortic valve repair. | |
| K. A. L. Müller, J. Brunner, N. Holzer, D. Rath, C. Zuern, M. Gawaz, T. Geisler, I. I. Müller (Tübingen) | ||
| (P477) | Serum cortisol as a strong predictor of cardiovascular-associated death after transcatheter aortic valve implantation | |
| A. Stundl, V. Adenauer, S. Pingel, M. Weber, A. Sedaghat, F. Mellert, W. Schiller, C. Hammerstingl, A. Welz, E. Grube, N. Werner, G. Nickenig, J.-M. Sinning (Bonn) | ||
| (P478) | Identification of circulating soluble RAGE (Receptor of Advanced Glycation End-products) as a novel prognostic and predictive biomarker of cardiovascular event risk in TAVI patients | |
| A. Stundl, V. Adenauer, S. Pingel, M. Weber, A. Sedaghat, F. Mellert, W. Schiller, C. Hammerstingl, A. Welz, E. Grube, N. Werner, N. Trimpop, S. Holdenrieder, G. Nickenig, J.-M. Sinning (Bonn) | ||
| (P479) | The obesity paradox in patients undergoing transcatheter aortic valve implantation | |
| N. Mangner, F. Woitek, S. Haussig, R. Höllriegel, G. Stachel, F. Schlotter, A. Lindner, S. Leontyev, D. Holzhey, F. W. Mohr, G. C. Schuler, A. Linke (Leipzig) |